Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

InflaRx NV buy Lifesci Capital

Start price
€5.34
05.04.23 / 50%
Target price
-
05.04.24
Performance (%)
-73.58%
End price
€1.41
06.04.24
Summary
This prediction ended on 06.04.24 with a price of €1.41. The BUY prediction by Lifesci_Capital for InflaRx NV performed very badly with a performance of -73.58%. Lifesci_Capital has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
InflaRx NV -1.477% -1.477% -71.335%
iShares Core DAX® 2.594% -1.861% 13.242%
iShares Nasdaq 100 3.553% -2.064% 38.293%
iShares Nikkei 225® 0.687% -8.704% 17.510%
iShares S&P 500 2.209% -1.988% 27.632%

Comments by Lifesci_Capital for this prediction

In the thread InflaRx NV diskutieren

InflaRx (NASDAQ: IFRX) was upgraded by analysts at Lifesci Capital from a "market perform" rating to an "outperform" rating.
Ratings data for IFRX provided by MarketBeat

In the thread Trading InflaRx NV
Prediction Buy
Perf. (%) -73.58%
Target price
Change
Ends at 05.04.24

Die von Lifesci_Capital gewählte maximale Laufzeit wurde überschritten